Table I. Summary of results concerning Clinical Evaluation and Karnofsky index for supportive oligonucleotide therapy (SOT). The percentages denote the efficacy of the method for three different cases taking into account: all samples, samples which were treated also with an adjunctive therapy and samples which were treated only with SOT (no extra therapy) or for which no information was available whether were treated or not with another therapy. For clinical evaluation efficacy was estimated as the sum of complete response (CR), partial response (PR), and stable disease (SD) and for Karnofsky Index values above 80 were considered. All cancer types were taken into account.